71st Congress of the Italian Embryological Group-Italian Society of Development and Cell Biology (GEI-SIBSC)

P24 | NUTRACEUTICAL-MEDIATED EFFECTS IN THE MODULATION OF INFLAMMATORY PROCESSES IN AN IN VITRO MODEL OF HUMAN ENDOMETRIAL STROMAL CELLS

L. Pietrobelli1, V.C. Divincenzo1, L. Sileo1, G. Scanavino1, E. Vicini2, L. Campagnolo3, V. Corsetti4, A.M. Tata1 | 1Dept. of Biology and Biotechnology “C. Darwin”, Sapienza University of Rome, Italy; 2Dept. of SAIMAL, Section of Histology, Sapienza University of Rome, Italy; 3Dept. of Biomedicine and Prevention, University of Rome Tor Vergata, Italy; 4Institute of Translational Pharmacology (IFT)-CNR, Rome, Italy

Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Published: 22 June 2026
4
Views
0
Downloads

Authors

The endometrial microenvironment is governed by a delicate equilibrium between inflammatory signaling and redox homeostasis, both essential for physiological processes such as tissue remodeling and decidualization. However, the transition from physiological signaling to chronic inflammation and oxidative stress represents a primary barrier to reproductive success. Excessive accumulation of reactive oxygen species (ROS) and pro-inflammatory microenvironment impair the molecular dialogue required for endometrial receptivity and follicle development. These alterations are frequently exacerbated by metabolic dysfunctions, such as insulin resistance (IR), which further compromise the functional integrity of human endometrial stromal cells (HESC).In this context, we investigated the potential protective role of nutraceutical substances, specifically the Oleoylethanolamide analog AM3102 and Quercetin (Q), in counteracting inflammation and metabolism-induced cellular dysfunctions. HESCs were exposed either to an inflammatory microenvironment mediated by Interleukin-1β (IL-1β) or to metabolic alteration via chronic insulin exposure (IR).Our findings demonstrate that both AM3102 and Quercetin promote the nuclear translocation of NRF2, a master regulator of anti-oxidant and anti-inflammatory responses. ROS quantification and mitochondrial tracking analyses, revealed a significant reduction in oxidative stress and modulation of mitochondrial dynamics. RT-PCR analysis indicated a modulation of the pro-inflammatory cytokine profile, while Western Blot analysis demonstrate the modulation of signaling pathways involved in both inflammatory and IR metabolic responses. Preliminary data obtained in human granulosa cells, confirm a similar cytoprotective profile, showing a marked reduction in ROS levels and further supporting the antioxidant efficacy of these nutraceutical compounds.

Downloads

Download data is not yet available.

Citations

How to Cite



1.
DELLO SVILUPPO E DELLA CELLULA G-SIDB. P24 | NUTRACEUTICAL-MEDIATED EFFECTS IN THE MODULATION OF INFLAMMATORY PROCESSES IN AN IN VITRO MODEL OF HUMAN ENDOMETRIAL STROMAL CELLS: L. Pietrobelli1, V.C. Divincenzo1, L. Sileo1, G. Scanavino1, E. Vicini2, L. Campagnolo3, V. Corsetti4, A.M. Tata1 | 1Dept. of Biology and Biotechnology “C. Darwin”, Sapienza University of Rome, Italy; 2Dept. of SAIMAL, Section of Histology, Sapienza University of Rome, Italy; 3Dept. of Biomedicine and Prevention, University of Rome Tor Vergata, Italy; 4Institute of Translational Pharmacology (IFT)-CNR, Rome, Italy. Eur J Histochem [Internet]. 2026 Jun. 22 [cited 2026 Jun. 28];70(s1). Available from: https://www.ejh.it/ejh/article/view/4720